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Abstract 
Epidemiological studies suggest that a moderate consumption of anthocyanins 
may be associated with protection against coronary heart disease. The main 
dietary sources of anthocyanins include red-coloured fruits and red wine. 
Although dietary anthocyanins comprise a diverse mixture of molecules, little is 
known how structural diversity relates to their bioavailability and biological 
function. The aim of the present study was to evaluate the absorption and 
metabolism of the 3-monoglucosides of delphinidin, cyanidin, petunidin, peonidin 
and malvidin in humans and to examine both the effect of consuming a red wine 
extract on plasma antioxidant status and on MCP-1 production in healthy human 
subjects.  
After a 12 h overnight fast, 7 healthy volunteers received 12 g of an anthocyanin 
extract and provided 13 blood samples in the 24 h following the test meal. 
Furthermore urine was collected during this 24h period. Anthocyanins were 
detected in their intact form in both plasma and urine samples. Other anthocyanin 
metabolites could also be detected in plasma and urine and were identified as 
glucuronides of peonidin and malvidin. Anthocyanins and their metabolites 
appeared in plasma about 30 minutes after ingestion of the test meal and reached 
their maximum value around 1.6 hours later for glucosides and 2.5 hours for 
glucuronides. Total urinary excretion of red wine anthocyanins was 0.05 ± 0.01% 
of the administered dose within 24 hours. About 94 % of the excreted 
anthocyanins were found in urine within 6 hours. In spite of the low concentration 
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of anthocyanins found in plasma, an increase in the antioxidant capacity and a 
decrease in MCP-1 circulating levels in plasma were observed. 
INTRODUCTION 
Anthocyanins are a group of natural occurring pigments responsible for the red-
blue colour of many fruits and vegetables. They are glycosides of the 
anthocyanidins which consist of various polyhydroxy or polymethoxy derivates of 
2-phenylbenzopyrylium or flavilium salts [1]. The intake of anthocyanins in 
humans, mainly ingested in the form of cyanidin derivatives from fruits and 
malvidin and related compounds from red wine, has been estimated to be between 
12 and 215 mg/day [2-4] which is higher than other flavonoids including 
quercetin, kaempferol, myricetin, apigenin, and luteolin [5]. The main sources of 
anthocyanins in the human diet are to be found in many red-coloured fruits, such 
as black currants, blueberries, red plums or cherries, cereals and vegetables, as 
well as in wine. Additionally, there is an increasing interest in the use of this 
group of natural colorants as food additives due to the negative attitude of 
consumers towards artificial alternatives. This growing use of anthocyanins in the 
food industry is likely to result in an increase in overall population consumption.  
However anthocyanin bioavailability is low with < 1% absorption of the ingested 
dose. Following absorption they appear in the blood and urine as glycosilated, 
methylated, glucuro-and/or sulfoconjugate forms. The recovery of anthocyanins 
and anthocyanins metabolites in urine has been estimated to be between 0.004 and 
0.11% of dose [6]. However most of the available data on anthocyanin 
bioavailability is based on studies carried out examining the metabolism of 
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cyanidin derivatives, from black currant or elderberry, pelargonidin glycosides 
from strawberries and delphinidin glycosides from blueberries. To date there is 
little information available on the absorption and subsequent metabolism and 
excretion of malvidin and other red wine/grape anthocyanidins which are main 
contributors to the total anthocyanin intake in Mediterranean countries. 
Epidemiological evidences as wells as in vitro and animal studies suggest that a 
moderate consumption of these anthocyanins may be associated with protection 
against cardiovascular diseases [7-8], chronic inflammation [9], and cancer [10]. 
Anthocyanins exhibit moderate free radical scavenging activity and have been 
shown to decrease tumour necrosis factor-alpha (TNF-)-induced monocyte 
chemoattractant protein (MCP-1) production in cultured endothelial cells and 
endothelioma cells [7,9-10]. MCP-1 is a CC chemokine shown to in part mediate 
the recruitment of macrophages to sites of infection or inflammation sites. 
Therefore the role of anthocyanidins as antioxidants and regulators of MCP-1 
expression are likely to make a significant contribution to their anti-atherogenic 
effects. 
However, in vivo data regarding the effect of red wine anthocyanins on MCP-1 
levels in humans are missing. Furthermore it is unclear if and to what extend red 
wine anthocyanins may affect the antioxidant capacity of human plasma. Thus, 
the objective of the present work was to study the bioavailability of red grape 
anthocyanins and to clarify the effect of their consumption on both plasma 
antioxidant status and MCP-1 concentrations. 
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METHODS AND MATERIALS 
Materials. 
All reagents were obtained from Sigma Aldrich (Madrid, Spain) unless otherwise 
stated and were of analytical or HPLC grade where applicable. Water was purified 
via a Milli Q plus system (Millipore, Bedford, MA). Enocianin (E-163), a Vitis 
vinifera grape peel anthocyanidin-rich extract, was kindly supplied by Sensient 
Food Colors Italy (Reggio Emilia, Italy). The 3-glucosides of pelargonidin, 
delphinidin, cyanidin, petunidin, peonidin and malvidin used as external standards 
were from Polyphenols AS (Sandnes, Norway). 
Chemical characterization of the anthocyanin extract 
All analyses were carried out using a Hewlett-Packard Agilent 1100 Series liquid 
chromatograph with a quaternary pump and photodiode array detector. The HPLC 
system was equipped with a Phenomenex Aqua C18 column (5 µm; 200 Å; 4.6 x 
150mm) which was set thermostatically at 35° C. Solvents used were aqueous 
0.1% trifluoracetic acid (A) and HPLC-grade acetonitrile (B) at a flow rate of 0.5 
mL/min. Starting isocratically with 10% B up to 20 min the gradient was 13% B 
from 20 to 35 min, 15% B from 35 to 55 min, 35% B from 55 to 65 min and 10% 
B from 65 to 70 min. Detection wavelengths  were 280, 360 and 520 nm. 
Analyses were carried out in triplicate.  
MS spectrometry was performed using a Finningan LCQ equipped with API 
surface, using an electrospray ionization (ESI) interface. The HPLC system was 
connected to the mass spectrometer probe via the diode array detector cell outlet 
using polyethyletherketone (PEEK) tubing. Both the auxiliary and the sheath gas 
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were a mixture of nitrogen and helium at flow rates of 1.2 and 6 L/min 
respectively. The capillary temperature was 195ºC and the capillary voltage was 4 
V. The MS detector was programmed to perform a series of three consecutive 
scans: a full scan from 120 to 1500 amu, an MS2 scan of the most abundant ion in 
the full mass, and MS3 of the most abundant ion in the MS2. The normalized 
energy of collision was 45 %. Spectra were recorded in the positive ion mode. 
Total anthocyanins in the grape extract were quantified at 520 nm as malvidin-3-
glucoside by integrating all the peaks. The concentration of 3-monoglucosides of 
delphinidin, cyanidin, petunidin, peonidin and malvidin in the sample was 
determined using commercially available standards. 
Human study. 
Human subjects: Seven healthy subjects were asked to participate in the study. 
Selection criteria were as follows: 26–36 y old; BMI between 20 and 28 kg/m2. 
Individuals with diagnosed CVD, liver disease or those with gastrointestinal 
disorders were not included. Furthermore individuals who consumed more than 
the recommended alcohol intakes (>14 and > 21 units per week for females and 
males) were ineligible to participate. The study was approved by the University of 
Reading Ethics and Research Committee (03/14) and the subjects were recruited 
from within the School of Food Biosciences. The single oral bolus dose acute 
study was conducted on seven healthy volunteers (two males, five females; 
average age 31y, average BMI 23.2 Kg). All subjects provided their written 
consent to participate in this study.  
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General procedure: Subjects were asked to refrain from consumption of 
anthocyanin-rich products such as wine, red fruits or derived products and other 
products rich in antioxidant polyphenols such as tomatoes, onions or tea, for 24 
hours prior to the acute study. Participants were required to come to the clinical 
investigation unit (CIU) at 8:00h in a 12h fasted state. Upon arrival at CIU, an 
intravenous cannula was inserted into a forearm (antecubital) vein and a 10 mL 
baseline blood sample was then taken into a heparin tube (BD Vacutainer® 
plasma tubes, Becton Dickinson, Franklin Lakes, NJ). The subjects then 
consumed 12 g of the anthocyanin extract together with 125 g of sugar-sweetened 
yogurt and a standard breakfast consisting of one and a half toast with butter and a 
glass of water. Standardised meals were also provided at lunch (cheese and salad 
sandwich, cheeps and chocolate bar) and dinner (pizza and banana) times (4 and 
10 h after anthocyanin consumption respectively). 
Blood samples (10 mL) were taken every 30 min for the first 3 h and every hour 
from the third hour onwards up to 10 h, and the final fasted sample taken at the 
24h time point. Blood samples were centrifuged at 3000 g for 10 min at 4ºC and 
aliquots of serum (2x0.5 mL) stored at –70ºC for analysis of MCP-1 and 
antioxidant activity. Plasma samples used for the quantification of anthocyanins 
and their metabolites were acidified by the addition of 0.2 mL of 0.44 mM TFA to 
0.7 mL of plasma and then stored at –70ºC until further analysis. 
Urine collections were made over the 24 hour study period at the following 
intervals: 0-3 h, 3-6 h, 6-10 h and 10-24 h after anthocyanin consumption. Urine 
 
8
was collected in 2.5 L flasks containing 2 g boric acid. 4 x 25 ml aliquots from 
each time interval collection were stored at –70ºC until further analysis. 
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Plasma analysis. 
For determination of the pharmacokinetic profile of anthocyanins, plasma samples 
were analysed by HPLC-DAD-MS after solid phase extraction using SPE C18 
cartridges. Pelargonidin-3-glucoside (35 pmol in 0.44 mM TFA), used as the 
internal standard, was added to acidified plasma samples (0.65 mL). 
Anthocyanins and their metabolites were extracted from plasma samples by using 
an octadecylsilane cartridge (Sep-pack C18, Waters, Massachussets, USA). Prior 
to sample elution, the solid phase cartridge was equilibrated with 7 mL methanol 
and then 7 mL 0.1 % TFA. Once the acidified plasma sample was deposited in the 
cartridge a first wash was done by eluting 7 mL of 0.1 % TFA. Finally the 
compounds of interest were eluted by adding 0.44 mM TFA in methanol. Samples 
were dried in a vacuum, taken up in 0.15 mL 0.44 TFA and centrifuged at 15000 
g for 10 min at room temperature. The supernatant (100 µL) was directly injected 
into the HPLC-DAD-MS system. 
HPLC, DAD and MS conditions were as required for the chemical 
characterization of the anthocyanin extract, as detailed above, except that the MS 
was programmed in 8 different segments according to the anthocyanin elution in 
order to improve the sensitivity of the method. Each of the segments was 
programmed to record a different SRM (selected reaction monitoring) 
corresponding to the break-up of the anthocyanin or metabolite of interest. 
Quantification of the different anthocyanins and their metabolites was done by 
integrating the MS-chromatograms and substitution in standard curves of the five 
anthocyanins against the area of the internal standard. In the case of the 
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glucuronides the quantification was done referred to their corresponding 
glucosides. Standard solutions were injected every day at the beginning and end 
of each HPLC sequence. The method was optimized and % recoveries of 60 ± 6, 
87 ± 5, 65 ± 4, 93 ± 5 and 107 ± 10 % respectively were evident for the 3-
monoglucosides of delphinidin, cyanidin, petunidin, peonidin and malvidin. Inter-
assay precision was determined by performing 10 independent analyses from a 
given sample showing a variation coefficient of 17%. Good linearity for the assay 
(r2 > 0.995) was found over the investigated calibration range of 1–1000 ng/mL 
for all the anthocyanins. The detection and quantification limits were in every 
case below 0.1 ng/mL.  
Urine analysis. 
Urine samples were analysed by HPLC-DAD-MS after solid phase extraction 
using SPE C18 cartridges. 0.17 mL HCl were added to 10 mL urine together with 
the internal standard, pelargonidin-3-glucoside (1.4 nmol in 0.44 mM TFA). 
Anthocyanins and their metabolites were extracted from urine samples by using 
the same procedure as that used for the plasma samples themselves, but with the 
exception that the final elution was carried out with 2 mL methanol:0.44 TFA in 
water (75:25,v:v). The supernatant (100 µL) was directly injected into the HPLC-
DAD-MS system under the same conditions as those for plasma samples. The 
method was optimized and % recoveries of 90 ± 8, 73 ± 4, 84 ± 4, 70 ± 5 and 100 
± 9 % respectively were observed for the 3-monoglucosides of delphinidin, 
cyanidin, petunidin, peonidin and malvidin. Inter-assay precision was determined 
in the same way as for plasma samples and showed a variation coefficient of 9 %. 
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Good linearity for the assay (r2 > 0.993) was found over the investigated 
calibration range of 1–1000 ng/mL for all the anthocyanins.  
Ferric reducing ability of plasma (FRAP)  
The FRAP assay was performed as previously described (11). FRAP reagent was 
freshly prepared each day by mixing together 10 mM 2,4,6-tripyridyl-s-triazine 
(TPTZ) and 20 mM iron (III) chloride in 0.25 M acetate buffer, pH 3.6. The 
absorbance of plasma samples as compared to Trolox was read at 593 nm (Power 
Wave XS, Biotek Instruments) 6 min after incubation at room temperature against 
a FRAP reagent blank and distilled water. FRAP values are expressed as Trolox 
equivalents. 
Trolox equivalent antioxidant capacity (TEAC)  
Sixteen hours prior to the assay being performed, the ABTS radical was prepared 
by adding 5 mL of a 4.9 mM potassium persulfate solution to 5 ml of a 14 mM 
ABTS solution (11). This solution was diluted in distilled water to yield an 
absorbance of 0.70 at 734 nm (Perkin Elmer UV/Vis Lambda Bio 20). The final 
reaction mixture contained 10 µL of standard or plasma in a 1 mL ABTS solution. 
The samples were vortexed for 10 s, and 6 min after the addition the absorbance at 
734 nm was recorded and compared to the ABTS radical solution plus distilled 
water. A standard curve was obtained by using Trolox as an internal standard 
(range: 0-100 µM). TEAC values express the µmols of Trolox equivalent to the 
antioxidant capacity of a 1.0 µmol solution of the test substance (12). 
Monocyte chemoattractant protein 1 (MCP-1). 
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The levels of MCP-1 in plasma were measured by using a commercially available 
ELISA kit (RD Systems Europe, Abingdon, UK.). Sera were diluted 1 in 3 for 
the quantification of MCP-1. The concentration of this molecule was calculated 
with reference to a standard curve performed with the corresponding recombinant 
molecule. All serum samples were tested in duplicate. 
Pharmacokinetic and statistical analysis. 
Curves were generated for each subject using a one-compartment model. The 
maximum plasma concentration (Cmax), and the time taken to reach maximum 
plasma concentration (tmax) were calculated from the observed values. The AUC 
from 0 to 24 hours were calculated by the linear trapezoidal method. The 
elimination rate constant (kel) was calculated by using the formula Ct = C0 x e-kelt 
and half life (t1/2) with the formula t1/2 = 0.693/ kel. Values are expressed as means 
± SEM of the seven subjects unless otherwise noted. Statistical analysis was 
carried out using ANOVA and Student t-test (SPSS for Windows version 15.0). 
 
RESULTS 
Characterization of the anthocyanin extract 
Anthocyanidin monoglucosides represented 71.2 % of the anthocyanins present in 
the anthocyanin extract used in this study. Acylated anthocyanins made up 23.8 % 
and the pyranoanthocyanin derivatives 5.0 % of the total amount of identified 
compounds. The total amount of anthocyanin monoglucosides in the 12 g of 
extract consumed in the test meal was 183.8 mg, of which the most abundant 
anthocyanin was malvidin-3-glucoside (89.9 mg), followed by delphinidin-3-
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glucoside (45.0 mg), petunidin-3-glucoside (33.8 mg), peonidin-3-glucoside (12.4 
mg) and cyanidin-3-glucoside (2.7 mg). 
Absorption of anthocyanins: plasma levels 
No anthocyanins were evident in the baseline plasma samples of the seven 
participants. After ingestion of the anthocyanin extract the malvidin and peonidin 
monoglucosides, as well as their glucuronides, could be detected and quantified in 
the plasma. The 3-monoglucosides of delphinidin and petunidin could be detected 
but were under the detection limit to allow accurate quantification. No detectable 
cyanidin-3-glucoside was present in any of the plasma samples collected follow 
anthocyanin administration. 
Figure 1 shows the kinetics of appearance of the different quantified pigments 
in the plasma over the study period (24 hours). The large errors bars demonstrate 
considerable inter-individual variations in the levels detected. In the case of the 
malvidin and peonidin glucuronides the large SD are in part due to the lack of 
detection of these metabolites in the plasma of two of the subjects participating in 
the study. As will be discussed later these same subjects presented very low levels 
of malvidin-glucuronide in their urine (< 5 μg). 
Table 1 shows plasma kinetic parameters of the quantified pigments. The 
average time required to reach maximum plasma concentration (tmax) for the 
glucosides was found to be 1.6 h. This is in agreement with published data where 
averages times were 1.5 h when anthocyanins are ingested together with solid 
foods as in our study [13]. Glucuronides reached their maximum concentration 
over a longer period of, around 2.3 h. thus indicating that anthocyanin 
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glucuronidation may take place, at least to some extent, in the liver. In general, the 
rapidity with which anthocyanins appear in the plasma may be explained by their 
ability to permeate the gastric mucosa as shown by Passamonti et al. [14] in a rat 
model.  
Maximum plasma concentrations (Cmax) reached after anthocyanin 
consumption corresponded with those described in other bioavailability studies 
using similar anthocyanin doses [15]. In the present work, following ingestion of 
90 mg malvidin-3-glucoside, the average maximum plasma levels reached were 
4.2 ± 1.3 nM in its intact form and 1.2 ± 0.9 nM as its conjugate metabolite with 
glucuronic acid.  
Cmax decreased in the following order: malvidin-3-glucoside, peonidin 
glucuronide, malvidin glucuronide and peonidin-3-glucoside. However, when 
normalising the Cmax with respect to the ingested doses of malvidin and peonidin 
glucosides, the decreasing order of the four pigments changed to: peonidin 
glucuronide, peonidin glucoside, malvidin glucoside and malvidin glucuronide. 
The Cmax for the two metabolic forms of peonidin together was 2.5 times greater 
than that of the two metabolic forms of malvidin together. In the same way, when 
normalizing the AUC with respect to the doses of peonidin and malvidin 
glucosides ingested, AUC decreased as follows: peonidin glucuronides (0.46 nmol 
h/L x mg-1), peonidin glucoside (0.25 nmol h/L mg-1), malvidin glucoside (0.19 
nmol h/L mg-1) and malvidin glucuronide (0.03 nmol h/L mg-1); with the AUC for 
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the total of peonidin metabolites three times higher than that of malvidin and its 
metabolite. 
In every case anthocyanins presented short half-lives. Glucuronic acid 
conjugates of the anthocyanins showed half-lives of 2.0 ± 1.1 and 1.3 ± 0.7 h for 
peonidin and malvidin glucuronides respectively. Again, anthocyanin half-lives 
showed large interindividual variations. The maximum variability was that of 
peonidin glucoside with a variation coefficient of 67.6 %, and half-life values of 
between 0.9 and 7.6 h. In contrast, in the case of malvidin-3-glucoside this 
variability was much lower with half-life values between 1 and 2.8 h. 
Urinary excretion profiles of the anthocyanins and their metabolites 
After ingestion of the enocyanin containing the five anthocyanidin glucosides, 
urinary excretion of the different metabolites was monitored for 24 h by HPLC-
DAD-MS analysis. Cyanidin-3-glucoside was the only anthocyanin that could not 
be quantified in urine even though it was detected in the urine of all seven 
subjects. Figure 2 shows, as an example, the HPLC-MS analysis of all the 
anthocyanins and their metabolites detected in the urine of the subjects. 
The total amount of anthocyanins in the urine, including the glucosides and 
glucuronides, after the 24 hour study was 0.074 mg (0.060-0.102 mg). Again, a 
marked interindividual variation was shown in the excreted amounts of each of 
the quantified pigments. The average amount of delphinidin-3-glucoside excreted 
was 0.013 mg with individual values between 0.008 and 0.017 mg. For petunidin-
3-glucoside the amount excreted in urine was 0.006 mg (0.002-0.010 mg). The 
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greatest inter-individual variations were to be found in the pigments of peonidin-
3-glucoside and malvidin glucuronides. In some of the volunteers the amounts of 
peonidin-3-glucoside excreted in urine were under the detection limit. On the 
other hand in the urine of some of the other subjects the excretion was 0.007 mg. 
Malvidin glucuronide was present in very low amounts in some cases (0.003-
0.005 mg); while in others the calculated amount of excretion went up to 0.041 
mg. In the case of peonidin glucuronide the amount excreted in urine was 
relatively constant (0.005 ± 0.001 mg), and the same occurred for malvidin-3-
glucoside (0.030 ± 0.007 mg). 
The average amount of total anthocyanins excreted in urine represented only 
0.05 ± 0.01 % of the total anthocyanins ingested with a range of 0.04 to 0.07% 
evident in the participants. Within the pigments quantified in urine, petunidin-3-
glucoside was the one presenting the lowest percentage of excretion, 0.03%. 
Delphinidin-3-glucoside, peonidin-3-glucoside and malvidin-3-glucoside showed 
identical percentages (0.06 %) of urinary excretion, in spite of the fact that for 
peonidin and malvidin, both the glucuronide and the glucoside forms were taken 
into account when calculating the percentage of excretion.  
Clear differences were shown in the excretion profile of anthocyanins. For 
instance, from the seven subjects in this study, two excreted most of the 
anthocyanins in their intact forms, as glucosides (87.1 ± 0.08 %). Two other 
participants in the study excreted 28.6 ± 3.8 % as glucuronides and only one of the 
subjects eliminated up to 50 % of the anthocyanins in urine as glucuronide. 
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Moreover, differences were shown in the form in which the monoglucosides of 
peonidin and malvidin were excreted in urine. In the case of the 24 hour excretion 
of peonidin-3-glucoside, 66 ± 25 % of it was in its conjugated form, whereas in 
the case of malvidin-3-glucoside only 32 ± 17 % was in its glucuronidated form. 
Anthocyanins and their metabolites were rapidly eliminated in urine. In the 
first six hours after anthocyanin ingestion 94 ± 7 % of the total anthocyanins 
eliminated had been excreted (figure 3). All the pigments quantified in the urine 
of the subjects had a period of maximum excretion of between 0 and 3 hours, with 
the exception of malvidin glucuronide which presented a slight delay in its period 
of maximum excretion, which was between 3 and 6 hours (49 ± 15 %). In this 
second period of time, between 3 and 6 hours, the elimination of peonidin 
glucuronide was also relatively high (43 ± 34 %).  
Since malvidin-3-glucoside represented approximately 60% of the ingested 
anthocyanins, the possible existence of other metabolites derived from this 
anthocyanin was carefully analysed. Other metabolites such as the sulphates, di-
glucuronides, sulphates-glucuronides and malvidin aglycon were monitored by 
LC-MS in the SIM mode for each individual ion. However, none of these 
metabolites were detected in any of the urine samples analysed. 
Antioxidant status 
Most authors have described maximum effects in the increment of the 
antioxidant power of plasma after approximately one hour of the ingestion of red 
wine [16-18]. Given this, together with the fact that anthocyanidins reached their 
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maximum plasma concentrations within the first 3 hours, antioxidant status 
measurements were only taken at every time point for the first 4 hours after the 
acute anthocyanin dose 
The values for antioxidant power obtained for the basal sample of each subject 
at 0 h (722-940 μmol of Trolox/L of plasma) were used as control values in order 
to evaluate the antioxidant effect of anthocyanin ingestion. Modest increases in 
FRAP values of the plasma samples were evident for every subject during the 
analysed period. However the observed increases did not reach statistical 
significance. In most of the subjects the maximum effect was observed after 0.5 h 
of treatment (4 to 15% increase in FRAP value), and only in two of them was the 
maximum observed after 2 h (4 to 22% increase in FRAP value). In the case of 
TEAC values, only two of the volunteers showed an increase in the antioxidant 
status, with no significant difference from baseline observed in the group as a 
whole 
Monocyte chemoattractant protein 1 (MCP-1). 
Previous work has demonstrated that red wine anthocyanins have an inhibitory 
effect on MCP-1 secretion in different endothelial cell models [7, 19-20]. 
Moreover, in a study carried out in rabbits ingesting a high cholesterol diet 
together with red wine for six weeks, a significant decrease in the expression of 
MCP-1 and its mRNA was shown [21]. 
In this work the circulating levels of MCP-1 have been monitored throughout 
the 24 h study time at 0, 3, 6, 10 and 24 h after anthocyanin ingestion. Basal 
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circulating levels of MCP-1 were considered in the normal range for all the 
volunteers (165 ± 43 pg/mL). Figure 4 shows the relative changes of MCP-1 in 
plasma samples for all the volunteers in the study. Only at 3 h the decrease on the 
circulating levels of MCP-1 (96 ± 42 pg/mL) was statistically significant. After 24 
h the levels of MCP-1 were again in the normal range (199 ± 118 pg/mL). 
DISCUSSION 
Anthocyanin absorption after a single dose of red grape extract is low (< 10 
nmol/L) with a marked interindividual variation in the maximum concentration 
reached for total anthocyanins and individual metabolites. The maximum 
concentrations in plasma for glucosides and glucuronides were reached at 1.6 h 
and 2.5 h respectively.  
Part of the inter-individual variation in the plasmatic levels of anthocyanin 
metabolites may be explained by biochemical factors such as differences in the 
expression or activity of enzymes involved in anthocyanin metabolism. 
Glucuronidation is catalyzed by UDP-glucuronosyltransferases (UGTs). To date, 
more than 20 UGT isoforms have been described, showing differences in their 
regulation, substrate selectivity and tissue distribution. In the gastrointestinal tract, 
members of the UGT1A are mainly expressed, and among them UGT1A1 which 
presents a high allelic variability is considered to be responsible, at least partially, 
for the marked interindividual variation in the oral bioavailability of a number of 
drugs [22]. Furthermore it is likely that this genetic polymorphism makes a 
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significant change in the rate of malvidin conjugation with glucuronic acid and its 
subsequent metabolism. 
The fact that the AUC for peonidin is three times higher than that of malvidin 
could indicate that peonidin is more bioavailable than malvidin. On the other 
hand, peonidin in plasma may also come from the physiological metabolism of 
other anthocyanins. For instance, cyanidin-3-glucoside methylation in its 3’ 
position would produce a peonidin-3-glucoside molecule. This interconversion 
has already being described by other authors in human studies [23-24]. However 
the marked differences between malvidin and peonidin AUCs may not be fully 
explained by this interconversion since the amount of cyanidin present in the 
anthocyanin extract was very low. Therefore, these differences in bioavailability 
of individual pigments indicates that the anthocyanin structure influences 
absorption, as has already being described for the petunidin, delphinidin and 
malvidin galactosides [25] and pelargonidin and cyanidin glucosides [24]. 
Total anthocyanins excreted in urine represented 0.05 % of the ingested 
amount. From this excreted amount, 72.4 ± 13.6 % was in its intact glucosylated 
form and 27.6 ± 13.4 % in its glucuronidated form. No data on the 
glucuronidation rate of peonidin and malvidin has been published so far. 
However, Felgines et al. [26] have reported an 80% excretion of pelargonidin-3-
glucoside in its glucuronidated form. After consumption of different glycosides of 
cyanidin only 6 to 14 % [4, 27] were excreted in their glucuronidated forms. 
These data may indicate that the process of conjugation with glucuronic acid 
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could be conditioned by the anthocyanidin structure. For this reason, pelargonidin, 
with only one hydroxyl group in the B-ring would impede to a lesser degree its 
conjugation with glucuronic acid than cyanidin, with two hydroxyl groups.  
Even if we could not detect any malvidin glucuronides in the urine or plasma 
of some of the subjects in this study, it should be noted that the glucuronide 
conjugate of peonidin was found in every subject, both in plasma and urine. 
Moreover, the levels of peonidin glucuronide were higher for longer than 
malvidin glucuronide despite the fact that the 12 g extract provided doses of 
peonidin approximately 7-fold lower than malvidin. This could be explained by 
the structural differences of the two anthocyanins, which may have an influence 
on the affinity of theses molecules for the enzymes involved in flavonoid 
glucuronidation. It might be that the molecule of malvidin with three substituents 
in the B-ring presents a greater steric impediment to interaction with the 
aforementioned enzyme than peonidin, with only two substituents in the B-ring. 
Even though the concentration of anthocyanins and their metabolites in plasma 
were in every case below 10 nmol/L for the given anthocyanin ingestion, a modest 
trend towards improvement in oxidant status and a decrease in the circulating 
levels of monocyte chemoattractant protein-1 was shown after ingestion of the 
anthocyanin extract for all the participating subjects. The chemokine MCP-1 is 
involved in atherogenesis through different mechanisms: it promotes the adhesion 
of blood circulating monocytes across the endothelium, participates in their 
recruitment into the subendothelium space and contributes to macrophage foam-
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cell differentiation. MCP-1 gene expression is in part mediated by the redox-
sensitive transcription factors NF-κB. Furthermore, in cultured monocytes, 
anthocyanins isolated from bilberries and black currants efficiently suppressed 
LPS-induced activation of NF-κB in vitro [28]. Since MCP-1 circulating levels in 
plasma were decreased by red wine anthocyanins in the current study, an 
inhibition of NF-kappa B signalling may be one potential mechanism by which 
anthocyanins may mediate anti-atherogenic properties.  
Furthermore polyphenols do not only work as antioxidants per se but can also 
induce the gene expression of other antioxidants via Nrf2 dependent signal 
transduction pathway [29] which may be also true for anthocyanidins.  
In a recent study by Gorelic et al. [30] it has been reported that wine 
polyphenols may inhibit the absorption of lipid peroxidation products, which may 
in turn decrease cellular oxidative stress.  
No doubt polyphenols exert their beneficial effect by a combination of 
mechanisms, all of them related to their well-known properties as antioxidants, 
metal chelators and their impact on cell signalling. However more human 
intervention studies, with larger populations and longer periods of treatment are 
needed in order to assess the potential benefits of red wine polyphenols on 
vascular health. 
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Table 1: Plasma kinetic parameters for the anthocyanin and their metabolites 
Pigment 
Ingested dose 
(mg) 
tmax 
(h) 
Cmax 
(nml/L) 
AUC 
(nmol h/L) 
t1/2 
(h) 
Peonidin-3-glucoside 15.2 ± 1.5 1.4 ± 0.8 0.8 ± 0.2 3.8 ± 1.6 3.7 ± 2.5 
Peonidin glucuronide  2.4 ± 0.2 1.7 ± 0.8 7.0 ± 3.2 2.0 ± 1.1 
Malvidin-3-glucoside 80.2 ± 3.1 1.8 ± 0.6 4.2 ± 1.3 15.0 ± 5.8 2.0 ± 0.6 
Malvidin glucuronide  2.6 ± 0.5 1.2 ± 0.9 2.3 ± 2.0 1.3 ± 0.7 
tmax, time to reach peak plasma concentration; Cmax, maximum plasma concentration; AUC, area under the curve; 
t1/2, half life 
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Figure 1. Plasma levels of the 3-glucoside (●) and 3-glucuronide (○) of malvidin 
(a) and peonidin (b) throughout the 24 hours of study. Values are means ± SD, n = 
7. 
 
Figure 2. MS chromatograms of the monoglucosides of anthocyanidin and their 
corresponding metabolites detected in the urine of one of the volunteers. Total ion 
current (A), delphinidin-3-glucoside (B), cyanidin-3-glucoside (C), petunidin-3-
glucoside (D), peonidin-3-glucoside (E), peonidin glucuronide (F), malvidin-3-
glucoside (G), malvidin glucuronide (H).  
 
Figure 3. Percentages of total anthocyanins excreted in the 24 h study period. 
 
Figure 4. Circulating MCP-1 levels expressed as percentages relative to the basal 
sample at time 0 h. Data are the mean ± standard deviation of the seven subjects. 
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